Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 18, 2023
Rethinking the When and Where of HIV PrEP service delivery
From the Ortblad Lab, Public Health Sciences Division
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
Biostatistician Dr. Deborah Donnell named AAAS Fellow
Honor recognizes her key role in HIV prevention studies
Tailoring vaccine trial recruitment to individual communities
From the HVTN, Vaccine and Infectious Disease Division
Preparing for coronavirus in your community
As experts warn of a pandemic, here's what you can do
New HIV vaccine trial to launch in U.S., Latin America and Europe
‘Mosaico’ will enroll 3,800 transgender people and men who have sex with men
Cutting-edge approach maps HIV's escape routes
Atlas of immune-evading HIV mutations could inform design of new treatments, vaccines
Meet Peru's HIV superhero
By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic
Community-building leads to record enrollment in HIV prevention study
Fighting the stigma of HIV among communities of color takes trust — and time
On World AIDS Day, renewed hope for an HIV vaccine
Clinical trial taking place in South Africa could 'dramatically alter the course of the pandemic’
Community is key for new, large HIV vaccine trial
Community trust is key as researchers start a new trial across 15 sites in South Africa
HIV prevention gains bring hope — and challenges
Injectable PrEP and other options are in the pipeline, and that makes clinical trials more complicated
A new path to an AIDS vaccine?
A ‘landmark’ clinical trial called the AMP study launches on three continents to test HIV-blocking super antibodies
Super survivors: What those with HIV who don't get sick can teach us
Meet five ‘HIV controllers,’ some positive for decades, who may hold clues to ending AIDS
WHO recommends daily HIV prevention pill for all men who have sex with men
But researchers caution daily adherence may not be realistic and are looking into alternatives
CDC recommends daily pill for those at high risk for HIV
Researchers work on long-lasting injectable drug; vaccine still ‘the holy grail’
Thai HIV vaccine trial follow-up studies offer possible explanation for HIV prevention success
Peter Gilbert and SCHARP researchers, HVTN Laboratory Program, part of worldwide effort to understand trial outcome, influence future HIV vaccine studies
SCHARP played key role in scientific breakthrough of the year
Science magazine selected HIV prevention trial for its top honor of 2011; study showed early antiretroviral therapy reduced heterosexual HIV transmission by 96 percent
Circumcision for HIV prevention
Citing a new study from Uganda, Dr. Judith Wasserheit's New England Journal of Medicine editorial concludes 'circumcision offers an important prevention opportunity and should be widely available'